Cardiology

Top Story

OPTIDUAL: Extended DAPT not superior to 12-month therapy

August 31, 2015

LONDON — Extending dual antiplatelet therapy with clopidogrel and aspirin for 48 months was not superior to 12 months of therapy for the reduction of net adverse clinical events in patients with drug-eluting stents, according to results of the OPTIDUAL trial.

However, the data indicated a “borderline but non-statistically significant reduction in post-hoc analysis of ischemic outcomes with extended dual antiplatelet therapy [DAPT],” Gérard Helft, MD, PhD, from the Institut de Cardiologie, Hôpital Pitié-Salpétrière, in Paris, France, said at the European Society of Cardiology Congress.

VIDEO: SCOT study addresses CV risk conferred by NSAIDs Meeting News CoverageVideo

VIDEO: SCOT study addresses CV risk conferred by NSAIDs

August 31, 2015
LONDON — In this video, Richard A. Chazal, MD, FACC, medical director of the Heart and Vascular Institute at Lee Memorial Health System, Fort Myers, Florida, and…
Bryan Williams Meeting News CoveragePerspective

PATHWAY-2: Spironolactone benefits patients with resistant hypertension

August 31, 2015
LONDON — In patients with resistant hypertension despite guideline-directed medical therapy, the addition of spironolactone produced a greater reduction in BP than…
In the Journals

Diabetes, depression predict poor survival, rehospitalization in patients with heart failure

August 31, 2015
Poorer survival and rehospitalization in patients with heart failure are associated with comorbid diabetes and depressive symptoms, according to recent study findings…
In the Journals

Readmission rates may skew hospital quality measurements

August 31, 2015
Readmission rates were an ineffective measure of a hospital’s quality because they did not take into account readmissions from different hospitals, resulting in a…
More News Headlines »
CME
PCI in ACS: Deciding Among Clopidogrel, Prasugrel, or Ticagrelor

PCI in ACS: Deciding Among Clopidogrel, Prasugrel, or Ticagrelor

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
Meeting News Coverage Video
VIDEO: ED protocol with high-sensitivity troponin assays helps rule out MI quickly

VIDEO: ED protocol with high-sensitivity troponin assays helps rule out MI quickly

August 30, 2015
LONDON — Joseph S. Alpert, MD, professor of medicine at the University of Arizona College of Medicine…
More »
CME
Spotlight on Hypercholesterolemia: New Ways to Test and Treat

Spotlight on Hypercholesterolemia: New Ways to Test and Treat

This activity is supported by an educational grant from Synageva BioPharma Corp.

Hereditary dyslipidemias are caused by single or multiple gene mutations that result in either overproduction or…
More »